Skip to main content
Tomáš Hanke

Tomáš Hanke

Professor of Vaccine Immunology, University of Oxford and a Distinguished Professor, Kumamoto University

Tomáš is a Professor of Vaccine Immunology at the University of Oxford and a Distinguished Professor at Kumamoto University in Japan. He has devoted his entire professional career to the development of a universal HIV-1 vaccine protecting against most global virus variants, including escape mutants. His basic research aims to understand what constitutes protective killer T cells against viral infections, as well as vaccine design and construction, and testing novel vaccine strategies in pre-clinical models while focusing on iterative improvements of the vaccine design driven by human data.

He oversees a programme of experimental medicine trials in the UK, Europe, the US and Africa. Tomáš and his partners aim to enhance research capacity and infrastructure on the African continent.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.